Honz Pharmaceutical Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 3, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020
Market Capitalization	4,356	2,230	2,642	2,799	3,906	2,529
Market Cap Growth	99.79%	-15.57%	-5.63%	-28.34%	54.45%	6.84%
Enterprise Value	4,848	2,676	3,033	3,196	4,251	2,952
Last Close Price	9.57	4.90	5.87	6.22	8.68	5.60
PE Ratio	-	-	229.10	-	355.50	270.79
Forward PE	-	36.32	36.32	36.32	36.32	36.32
PS Ratio	10.00	4.72	3.57	5.22	4.67	2.74
PB Ratio	4.06	1.91	1.92	2.07	2.51	1.58
P/TBV Ratio	4.66	2.26	2.27	2.48	3.05	2.46
P/FCF Ratio	285.71	-	-	-	-	-
P/OCF Ratio	35.31	31.21	37.37	95.45	344.77	-
EV/Sales Ratio	11.13	5.66	4.10	5.97	5.08	3.20
EV/EBITDA Ratio	-	-	22.93	-	126.48	25.22
EV/EBIT Ratio	-	-	55.30	-	-	44.10
EV/FCF Ratio	318.00	-	-	-	-	-
Debt / Equity Ratio	0.45	0.44	0.36	0.43	0.38	0.39
Debt / EBITDA Ratio	-	-	3.79	-	15.09	5.31
Debt / FCF Ratio	31.90	-	-	-	-	-
Asset Turnover	0.22	0.23	0.33	0.23	0.33	0.38
Inventory Turnover	1.07	1.06	1.47	1.46	2.05	2.38
Quick Ratio	0.21	0.42	0.85	0.79	0.99	0.76
Current Ratio	0.67	0.89	1.60	1.33	1.49	1.22
Return on Equity (ROE)	-16.80%	-17.65%	0.38%	-13.61%	0.67%	1.25%
Return on Assets (ROA)	-3.92%	-4.73%	1.54%	-3.86%	-0.13%	1.74%
Return on Invested Capital (ROIC)	-8.10%	-9.51%	0.71%	-8.25%	-0.14%	2.57%
Return on Capital Employed (ROCE)	-8.80%	-10.60%	3.10%	-8.20%	-0.30%	3.30%
Earnings Yield	-4.36%	-9.70%	0.44%	-6.70%	0.28%	0.37%
FCF Yield	0.35%	-0.94%	-2.53%	-1.06%	-5.34%	-12.51%
Dividend Yield	-	-	-	-	-	0.36%
Payout Ratio	-	-	211.14%	-	370.22%	241.72%
Buyback Yield / Dilution	-0.58%	-1.34%	-0.10%	0.08%	-0.29%	0.23%
Total Shareholder Return	-0.58%	-1.34%	-0.10%	0.08%	-0.29%	0.59%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.